Triumvira Immunologics

Austin, United States

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

Mar 2022

Series A

Biotechnology Clinical Trials Health Care

Top Investors

B CapitalNorthpond VenturesOceanpine CapitalLeaps by BayerViva Biotech

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Triumvira Immunologics

Who are Triumvira Immunologics's investors?

Triumvira Immunologics's investors include B Capital, Northpond Ventures, Oceanpine Capital, Leaps by Bayer, Viva Biotech.

Where is Triumvira Immunologics headquartered?

Triumvira Immunologics is headquartered in Austin, United States.

What does Triumvira Immunologics do?

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

What stage is Triumvira Immunologics at?

Triumvira Immunologics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 17, 2022.

MLA

"Triumvira Immunologics — Funding & Investors." VCBacked, March 17, 2022, https://www.vcbacked.co/company/triumvira-immunologics. Accessed July 1, 2026.

APA

VCBacked. (2022). Triumvira Immunologics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/triumvira-immunologics

Wikipedia (cite web)

{{cite web |title=Triumvira Immunologics — Funding & Investors |url=https://www.vcbacked.co/company/triumvira-immunologics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 17, 2022.